A0779512
ARN-509 , ≥98% , 956104-40-8
CAS NO.:956104-40-8
Empirical Formula: C21H15F4N5O2S
Molecular Weight: 477.43
MDL number: MFCD22380626
EINECS: 807-449-9
Pack Size | Price | Stock | Quantity |
5MG | RMB455.20 | In Stock |
|
25MG | RMB1143.20 | In Stock |
|
100MG | RMB3039.20 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Density | 1.59±0.1 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | ≥23.85 mg/mL in DMSO; insoluble in H2O; ≥7.33 mg/mL in EtOH |
form | solid |
pka | 13.83±0.46(Predicted) |
color | White to off-white |
InChI | InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31) |
InChIKey | HJBWBFZLDZWPHF-UHFFFAOYSA-N |
SMILES | C(NC)(=O)C1=CC=C(N2C(=S)N(C3=CC(C(F)(F)F)=C(C#N)N=C3)C(=O)C32CCC3)C=C1F |
Description and Uses
Apalutamide is a second-generation antiandrogen used in the treatment of prostate cancer. It is a potent antagonist of androgen receptor with IC50 value of 16 nM. Binds androgen receptors, thereby inhibiting nuclear translocation, DNA binding and transcriptional activation. ARN-509 has therapeutic applications in non-metastatic, castration-resistant prostate cancer.
Safety
Symbol(GHS) | ![]() GHS07 |
Signal word | Warning |
Hazard statements | H302 |
Precautionary statements | P280-P305+P351+P338 |